Clorox (CLX) Tops Q1 EPS by 4c, Trims FY EPS Guidance

Clorox (NYSE: CLX) reported Q1 EPS of $1.62, $0.04 better than the analyst estimate of $1.58. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.54 billion.

GUIDANCE:

Clorox sees FY2019 EPS of $6.20-$6.40, versus the consensus of $6.41.

• 2% to 4% sales growth (unchanged)

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Stardust Power (SDST) Tops Q2 EPS by 1c